Best Buy Stocks (ORIGINAL — PICK)

: Up over 204% YTD following successful Phase 3 trials for its psoriasis therapy.

Expert services like Morningstar and The Motley Fool have identified these as top picks for long-term holding. NASDAQ:NVDA best buy stocks

: Up roughly 394% YTD following the commercial launch of its cancer therapy, Anktiva, in Saudi Arabia and expansion into Europe. : Up over 204% YTD following successful Phase

Several companies have seen triple-digit gains in the first four months of 2026, often led by specialized healthcare breakthroughs or critical AI hardware components. best buy stocks